Safety of Lenadogene Nolparvovec Gene Therapy Over 5 Years in 189 Patients With Leber Hereditary Optic Neuropathy
Open Access
- 8 December 2022
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 249, 108-125
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Gene Therapy for Leber Hereditary Optic NeuropathyOphthalmology, 2016
- Nuclear expression of mitochondrial ND4 leads to the protein assembling in complex I and prevents optic atrophy and visual lossMolecular Therapy - Methods & Clinical Development, 2015
- Safety and Effects of the Vector for the Leber Hereditary Optic Neuropathy Gene Therapy Clinical TrialJAMA Ophthalmology, 2014
- A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathyBrain, 2011
- Preclinical Safety Evaluation of AAV2-sFLT01— A Gene Therapy for Age-related Macular DegenerationMolecular Therapy, 2011
- Retinal ganglion cell neurodegeneration in mitochondrial inherited disordersBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2009
- Safety and Efficacy of Gene Transfer for Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International WorkshopAmerican Journal of Ophthalmology, 2005
- Leber's "plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Standardizatlon of Vitreal inflammatory Activity in Intermediate and Posterior UveitisOphthalmology, 1985